^
BIOMARKER:

STRN-ALK fusion + MET amplification

i
Other names: STRN, Striatin, Protein Phosphatase 2 Regulatory Subunit B'''Alpha, Striatin Calmodulin Binding Protein, Striatin Calmodulin-Binding Protein, PPP2R6A, SG2NA, STRN1, NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor, DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Entrez ID:
News
Twitter
Trials
STRN-ALK fusion + MET amplification
NSCLC
alectinib
Sensitive: C3 – Early Trials
J Cell Mol Med - 3 weeks
STRN-ALK fusion + MET amplification
NSCLC
crizotinib + X-396
Sensitive: C3 – Early Trials
J Cell Mol Med - 3 weeks